Figure 2From: Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancersMSeA effect on the nuclear expression of β-catenin. Colorectal cancer cells express a high-level of nuclear β-catenin indicating activation (panel 2A). Treatment with MSeA results in inhibition of the nuclear expression of β-catenin indicating suppression of the active form of β-catenin (panel 2B).Back to article page